Exodus Point Capital Management, LP Neu Base Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

  • $13.1 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$7.25 - $9.71 $81,200 - $108,752
-11,200 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$6.69 - $11.51 $4,014 - $6,906
-600 Reduced 5.08%
11,200 $98,000
Q1 2020

May 15, 2020
SELL
$4.77 - $8.23 $1,955 - $3,374
-410 Reduced 3.36%
11,800 $84,000
Q4 2019

Feb 14, 2020
BUY
$4.5 - $8.1 $54,945 - $98,901
12,210 New
12,210 $88,000

About NeuBase Therapeutics, Inc.

NBSE Quotes by TradingView
  • Ticker NBSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,258,700
  • Description
  • NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...
More about NBSE
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email